Publications by authors named "Megumi Mathison"

Claim this Profile
A
Activation of a GPCR, ORL1 Receptor: A Novel Therapy to Prevent Heart Failure Progression.
Saliha S Pathan, Aarthi Pugazenthi, Beverly R E A Dixon, Theodore G Wensel, Todd K Rosengart, Megumi Mathison

J Cardiovasc Dev Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential.
Hong Gao, Saliha Pathan, Beverly R E A Dixon, Aarthi Pugazenthi, Megumi Mathison

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression.
Saliha Pathan, Aarthi Pugazenthi, Beverly Rea Dixon, Theodore G Wensel, Todd K Rosengart, Megumi Mathison

Res Sq· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct cardiac reprogramming: A new technology for cardiac repair.
Paige E Brlecic, Clark A Bonham, Todd K Rosengart, Megumi Mathison

J Mol Cell Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation.
Jaya Pratap Pinnamaneni, Vivek P Singh, Mary B Kim, Christopher T Ryan, Aarthi Pugazenthi, Megumi Mathison

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming.
Vivek P Singh, Jaya P Pinnamaneni, Aarthi Pugazenthi, Deepthi Sanagasetti, Megumi Mathison

J Am Heart Assoc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast transition to an endothelial "trans" state improves cell reprogramming efficiency.
Megumi Mathison, Deepthi Sanagasetti, Vivek P Singh, Aarthi Pugazenthi, Jaya Pratap Pinnamaneni

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium.
Ravi K Ghanta, Samira Aghlara-Fotovat, Aarthi Pugazenthi, Christopher T Ryan, Vivek P Singh, Megumi Mathison

Biomater Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming.
Vivek P Singh, Jaya Pratap Pinnamaneni, Aarthi Pugazenthi, Deepthi Sanagasetti, Megumi Mathison

J Am Heart Assoc· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells.
Vivekkumar Patel, Vivek P Singh, Jaya Pratap Pinnamaneni, Deepthi Sanagasetti, Jacqueline Olive, Megumi Mathison

J Thorac Cardiovasc Surg· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart regeneration: The endothelial cell comes first.
Megumi Mathison, Todd K Rosengart

J Thorac Cardiovasc Surg· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail.
Megumi Mathison, Vivek P Singh, Deepthi Sanagasetti, Lina Yang, Jaya Pratap Pinnamaneni

J Thorac Cardiovasc Surg· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Lina Yang, Li Liu, Hong Gao, Jaya Pratap Pinnamaneni, Deepthi Sanagasetti, Megumi Mathison

J Hematol Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.
Megumi Mathison, Vivek P Singh, Maria J Chiuchiolo, Deepthi Sanagasetti, Yun Mao

J Thorac Cardiovasc Surg· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1.
Vivek P Singh, Megumi Mathison, Vivekkumar Patel, Deepthi Sanagasetti, Brian W Gibson

J Am Heart Assoc· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Cardiac Cellular Reprogramming for Cardiac Regeneration.
Vivekkumar Patel, Megumi Mathison, Vivek P Singh, Jianchang Yang, Todd K Rosengart

Curr Treat Options Cardiovasc Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors.
Megumi Mathison, Vivek P Singh, Robert P Gersch, Maricela O Ramirez, Austin Cooney

J Thorac Cardiovasc Surg· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.
Megumi Mathison, Robert P Gersch, Ahmed Nasser, Sarit Lilo, Mallory Korman

J Am Heart Assoc· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materials.
Jianhua Cui, Jinsheng Li, Megumi Mathison, Fernando Tondato, Stephen P Mulkey

Cardiovasc Revasc Med· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular matrix scaffold for cardiac repair.
Keith A Robinson, Jinshen Li, Megumi Mathison, Alka Redkar, Jianhua Cui

Circulation· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of problematic access in transluminal endografting of abdominal aortic aneurysm.
Megumi N Mathison, Gary J Becker, Barry T Katzen, James F Benenati, Gerald Zemel

J Vasc Interv Radiol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transluminal repair of abdominal aortic aneurysm: a call for selective use, careful surveillance, new device design, and systematic study of transrenal fixation.
Gary J Becker, Margaret Kovacs, Megumi N Mathison

J Vasc Surg· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis